▶ 調査レポート

薬剤溶出性ビーズの世界市場(~2026年)

• 英文タイトル:Global Drug Eluting Beads Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。薬剤溶出性ビーズの世界市場(~2026年) / Global Drug Eluting Beads Market Insights and Forecast to 2026 / MRC2-11QY05440資料のイメージです。• レポートコード:MRC2-11QY05440
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は薬剤溶出性ビーズのグローバル市場について調査・分析したレポートです。種類別(オンコゼンビーズ、クアドラスフィア、LCビーズ、その他)市場規模、用途別(病院、専門クリニック、研究センター、外来外科センター)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別薬剤溶出性ビーズの競争状況、市場シェア
・世界の薬剤溶出性ビーズ市場:種類別市場規模 2015年-2020年(オンコゼンビーズ、クアドラスフィア、LCビーズ、その他)
・世界の薬剤溶出性ビーズ市場:種類別市場規模予測 2021年-2026年(オンコゼンビーズ、クアドラスフィア、LCビーズ、その他)
・世界の薬剤溶出性ビーズ市場:用途別市場規模 2015年-2020年(病院、専門クリニック、研究センター、外来外科センター)
・世界の薬剤溶出性ビーズ市場:用途別市場規模予測 2021年-2026年(病院、専門クリニック、研究センター、外来外科センター)
・北米の薬剤溶出性ビーズ市場分析:米国、カナダ
・ヨーロッパの薬剤溶出性ビーズ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの薬剤溶出性ビーズ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の薬剤溶出性ビーズ市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの薬剤溶出性ビーズ市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Biocompatibles、BTG International、Merit Medical Systems、CeloNova BioSciences、ABK Biomedical、Boston Scientific、Medtronic、Merit Medical Systems、Surefire Medical、Terumo
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.

Market Analysis and Insights: Global Drug Eluting Beads Market
The global Drug Eluting Beads market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Drug Eluting Beads Scope and Market Size
Drug Eluting Beads market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Beads market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Drug Eluting Beads market is segmented into
Oncozene Beads
Quadra Sphere
LC Beads
Others

Segment by Application, the Drug Eluting Beads market is segmented into
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers

Regional and Country-level Analysis
The Drug Eluting Beads market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Eluting Beads market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drug Eluting Beads Market Share Analysis
Drug Eluting Beads market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug Eluting Beads business, the date to enter into the Drug Eluting Beads market, Drug Eluting Beads product introduction, recent developments, etc.

The major vendors covered:
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo

レポート目次

1 Study Coverage
1.1 Drug Eluting Beads Product Introduction
1.2 Market Segments
1.3 Key Drug Eluting Beads Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drug Eluting Beads Market Size Growth Rate by Type
1.4.2 Oncozene Beads
1.4.3 Quadra Sphere
1.4.4 LC Beads
1.4.5 Others
1.5 Market by Application
1.5.1 Global Drug Eluting Beads Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Research Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drug Eluting Beads Market Size, Estimates and Forecasts
2.1.1 Global Drug Eluting Beads Revenue 2015-2026
2.1.2 Global Drug Eluting Beads Sales 2015-2026
2.2 Global Drug Eluting Beads, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Drug Eluting Beads Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Drug Eluting Beads Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Drug Eluting Beads Competitor Landscape by Players
3.1 Drug Eluting Beads Sales by Manufacturers
3.1.1 Drug Eluting Beads Sales by Manufacturers (2015-2020)
3.1.2 Drug Eluting Beads Sales Market Share by Manufacturers (2015-2020)
3.2 Drug Eluting Beads Revenue by Manufacturers
3.2.1 Drug Eluting Beads Revenue by Manufacturers (2015-2020)
3.2.2 Drug Eluting Beads Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drug Eluting Beads Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drug Eluting Beads Revenue in 2019
3.2.5 Global Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Drug Eluting Beads Price by Manufacturers
3.4 Drug Eluting Beads Manufacturing Base Distribution, Product Types
3.4.1 Drug Eluting Beads Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug Eluting Beads Product Type
3.4.3 Date of International Manufacturers Enter into Drug Eluting Beads Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Drug Eluting Beads Market Size by Type (2015-2020)
4.1.1 Global Drug Eluting Beads Sales by Type (2015-2020)
4.1.2 Global Drug Eluting Beads Revenue by Type (2015-2020)
4.1.3 Drug Eluting Beads Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drug Eluting Beads Market Size Forecast by Type (2021-2026)
4.2.1 Global Drug Eluting Beads Sales Forecast by Type (2021-2026)
4.2.2 Global Drug Eluting Beads Revenue Forecast by Type (2021-2026)
4.2.3 Drug Eluting Beads Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drug Eluting Beads Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Drug Eluting Beads Market Size by Application (2015-2020)
5.1.1 Global Drug Eluting Beads Sales by Application (2015-2020)
5.1.2 Global Drug Eluting Beads Revenue by Application (2015-2020)
5.1.3 Drug Eluting Beads Price by Application (2015-2020)
5.2 Drug Eluting Beads Market Size Forecast by Application (2021-2026)
5.2.1 Global Drug Eluting Beads Sales Forecast by Application (2021-2026)
5.2.2 Global Drug Eluting Beads Revenue Forecast by Application (2021-2026)
5.2.3 Global Drug Eluting Beads Price Forecast by Application (2021-2026)

6 North America
6.1 North America Drug Eluting Beads by Country
6.1.1 North America Drug Eluting Beads Sales by Country
6.1.2 North America Drug Eluting Beads Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Drug Eluting Beads Market Facts & Figures by Type
6.3 North America Drug Eluting Beads Market Facts & Figures by Application

7 Europe
7.1 Europe Drug Eluting Beads by Country
7.1.1 Europe Drug Eluting Beads Sales by Country
7.1.2 Europe Drug Eluting Beads Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug Eluting Beads Market Facts & Figures by Type
7.3 Europe Drug Eluting Beads Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Drug Eluting Beads by Region
8.1.1 Asia Pacific Drug Eluting Beads Sales by Region
8.1.2 Asia Pacific Drug Eluting Beads Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Drug Eluting Beads Market Facts & Figures by Type
8.3 Asia Pacific Drug Eluting Beads Market Facts & Figures by Application

9 Latin America
9.1 Latin America Drug Eluting Beads by Country
9.1.1 Latin America Drug Eluting Beads Sales by Country
9.1.2 Latin America Drug Eluting Beads Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Drug Eluting Beads Market Facts & Figures by Type
9.3 Central & South America Drug Eluting Beads Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Drug Eluting Beads by Country
10.1.1 Middle East and Africa Drug Eluting Beads Sales by Country
10.1.2 Middle East and Africa Drug Eluting Beads Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Drug Eluting Beads Market Facts & Figures by Type
10.3 Middle East and Africa Drug Eluting Beads Market Facts & Figures by Application

11 Company Profiles
11.1 Biocompatibles
11.1.1 Biocompatibles Corporation Information
11.1.2 Biocompatibles Description and Business Overview
11.1.3 Biocompatibles Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biocompatibles Drug Eluting Beads Products Offered
11.1.5 Biocompatibles Related Developments
11.2 BTG International
11.2.1 BTG International Corporation Information
11.2.2 BTG International Description and Business Overview
11.2.3 BTG International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BTG International Drug Eluting Beads Products Offered
11.2.5 BTG International Related Developments
11.3 Merit Medical Systems
11.3.1 Merit Medical Systems Corporation Information
11.3.2 Merit Medical Systems Description and Business Overview
11.3.3 Merit Medical Systems Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merit Medical Systems Drug Eluting Beads Products Offered
11.3.5 Merit Medical Systems Related Developments
11.4 CeloNova BioSciences
11.4.1 CeloNova BioSciences Corporation Information
11.4.2 CeloNova BioSciences Description and Business Overview
11.4.3 CeloNova BioSciences Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CeloNova BioSciences Drug Eluting Beads Products Offered
11.4.5 CeloNova BioSciences Related Developments
11.5 ABK Biomedical
11.5.1 ABK Biomedical Corporation Information
11.5.2 ABK Biomedical Description and Business Overview
11.5.3 ABK Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ABK Biomedical Drug Eluting Beads Products Offered
11.5.5 ABK Biomedical Related Developments
11.6 Boston Scientific
11.6.1 Boston Scientific Corporation Information
11.6.2 Boston Scientific Description and Business Overview
11.6.3 Boston Scientific Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boston Scientific Drug Eluting Beads Products Offered
11.6.5 Boston Scientific Related Developments
11.7 Medtronic
11.7.1 Medtronic Corporation Information
11.7.2 Medtronic Description and Business Overview
11.7.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Medtronic Drug Eluting Beads Products Offered
11.7.5 Medtronic Related Developments
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Corporation Information
11.8.2 Merit Medical Systems Description and Business Overview
11.8.3 Merit Medical Systems Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merit Medical Systems Drug Eluting Beads Products Offered
11.8.5 Merit Medical Systems Related Developments
11.9 Surefire Medical
11.9.1 Surefire Medical Corporation Information
11.9.2 Surefire Medical Description and Business Overview
11.9.3 Surefire Medical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Surefire Medical Drug Eluting Beads Products Offered
11.9.5 Surefire Medical Related Developments
11.10 Terumo
11.10.1 Terumo Corporation Information
11.10.2 Terumo Description and Business Overview
11.10.3 Terumo Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Terumo Drug Eluting Beads Products Offered
11.10.5 Terumo Related Developments
11.1 Biocompatibles
11.1.1 Biocompatibles Corporation Information
11.1.2 Biocompatibles Description and Business Overview
11.1.3 Biocompatibles Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biocompatibles Drug Eluting Beads Products Offered
11.1.5 Biocompatibles Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Drug Eluting Beads Market Estimates and Projections by Region
12.1.1 Global Drug Eluting Beads Sales Forecast by Regions 2021-2026
12.1.2 Global Drug Eluting Beads Revenue Forecast by Regions 2021-2026
12.2 North America Drug Eluting Beads Market Size Forecast (2021-2026)
12.2.1 North America: Drug Eluting Beads Sales Forecast (2021-2026)
12.2.2 North America: Drug Eluting Beads Revenue Forecast (2021-2026)
12.2.3 North America: Drug Eluting Beads Market Size Forecast by Country (2021-2026)
12.3 Europe Drug Eluting Beads Market Size Forecast (2021-2026)
12.3.1 Europe: Drug Eluting Beads Sales Forecast (2021-2026)
12.3.2 Europe: Drug Eluting Beads Revenue Forecast (2021-2026)
12.3.3 Europe: Drug Eluting Beads Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Drug Eluting Beads Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Drug Eluting Beads Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Drug Eluting Beads Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Drug Eluting Beads Market Size Forecast by Region (2021-2026)
12.5 Latin America Drug Eluting Beads Market Size Forecast (2021-2026)
12.5.1 Latin America: Drug Eluting Beads Sales Forecast (2021-2026)
12.5.2 Latin America: Drug Eluting Beads Revenue Forecast (2021-2026)
12.5.3 Latin America: Drug Eluting Beads Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Drug Eluting Beads Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Drug Eluting Beads Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Drug Eluting Beads Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Drug Eluting Beads Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Drug Eluting Beads Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug Eluting Beads Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Drug Eluting Beads Market Segments
Table 2. Ranking of Global Top Drug Eluting Beads Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug Eluting Beads Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oncozene Beads
Table 5. Major Manufacturers of Quadra Sphere
Table 6. Major Manufacturers of LC Beads
Table 7. Major Manufacturers of Others
Table 8. Global Drug Eluting Beads Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Drug Eluting Beads Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Drug Eluting Beads Sales by Regions 2015-2020 (K MT)
Table 11. Global Drug Eluting Beads Sales Market Share by Regions (2015-2020)
Table 12. Global Drug Eluting Beads Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Drug Eluting Beads Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Drug Eluting Beads Sales Share by Manufacturers (2015-2020)
Table 15. Global Drug Eluting Beads Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Drug Eluting Beads by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Beads as of 2019)
Table 17. Drug Eluting Beads Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Drug Eluting Beads Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Drug Eluting Beads Price (2015-2020) (USD/MT)
Table 20. Drug Eluting Beads Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Drug Eluting Beads Product Type
Table 22. Date of International Manufacturers Enter into Drug Eluting Beads Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Drug Eluting Beads Sales by Type (2015-2020) (K MT)
Table 25. Global Drug Eluting Beads Sales Share by Type (2015-2020)
Table 26. Global Drug Eluting Beads Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Drug Eluting Beads Revenue Share by Type (2015-2020)
Table 28. Drug Eluting Beads Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Drug Eluting Beads Sales by Application (2015-2020) (K MT)
Table 30. Global Drug Eluting Beads Sales Share by Application (2015-2020)
Table 31. North America Drug Eluting Beads Sales by Country (2015-2020) (K MT)
Table 32. North America Drug Eluting Beads Sales Market Share by Country (2015-2020)
Table 33. North America Drug Eluting Beads Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Drug Eluting Beads Revenue Market Share by Country (2015-2020)
Table 35. North America Drug Eluting Beads Sales by Type (2015-2020) (K MT)
Table 36. North America Drug Eluting Beads Sales Market Share by Type (2015-2020)
Table 37. North America Drug Eluting Beads Sales by Application (2015-2020) (K MT)
Table 38. North America Drug Eluting Beads Sales Market Share by Application (2015-2020)
Table 39. Europe Drug Eluting Beads Sales by Country (2015-2020) (K MT)
Table 40. Europe Drug Eluting Beads Sales Market Share by Country (2015-2020)
Table 41. Europe Drug Eluting Beads Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Drug Eluting Beads Revenue Market Share by Country (2015-2020)
Table 43. Europe Drug Eluting Beads Sales by Type (2015-2020) (K MT)
Table 44. Europe Drug Eluting Beads Sales Market Share by Type (2015-2020)
Table 45. Europe Drug Eluting Beads Sales by Application (2015-2020) (K MT)
Table 46. Europe Drug Eluting Beads Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Drug Eluting Beads Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Drug Eluting Beads Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Drug Eluting Beads Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Drug Eluting Beads Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Drug Eluting Beads Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Drug Eluting Beads Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Drug Eluting Beads Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Drug Eluting Beads Sales Market Share by Application (2015-2020)
Table 55. Latin America Drug Eluting Beads Sales by Country (2015-2020) (K MT)
Table 56. Latin America Drug Eluting Beads Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Drug Eluting Beads Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Drug Eluting Beads Revenue Market Share by Country (2015-2020)
Table 59. Latin America Drug Eluting Beads Sales by Type (2015-2020) (K MT)
Table 60. Latin America Drug Eluting Beads Sales Market Share by Type (2015-2020)
Table 61. Latin America Drug Eluting Beads Sales by Application (2015-2020) (K MT)
Table 62. Latin America Drug Eluting Beads Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Drug Eluting Beads Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Drug Eluting Beads Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Drug Eluting Beads Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Drug Eluting Beads Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Drug Eluting Beads Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Drug Eluting Beads Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Drug Eluting Beads Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Drug Eluting Beads Sales Market Share by Application (2015-2020)
Table 71. Biocompatibles Corporation Information
Table 72. Biocompatibles Description and Major Businesses
Table 73. Biocompatibles Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Biocompatibles Product
Table 75. Biocompatibles Recent Development
Table 76. BTG International Corporation Information
Table 77. BTG International Description and Major Businesses
Table 78. BTG International Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. BTG International Product
Table 80. BTG International Recent Development
Table 81. Merit Medical Systems Corporation Information
Table 82. Merit Medical Systems Description and Major Businesses
Table 83. Merit Medical Systems Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Merit Medical Systems Product
Table 85. Merit Medical Systems Recent Development
Table 86. CeloNova BioSciences Corporation Information
Table 87. CeloNova BioSciences Description and Major Businesses
Table 88. CeloNova BioSciences Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. CeloNova BioSciences Product
Table 90. CeloNova BioSciences Recent Development
Table 91. ABK Biomedical Corporation Information
Table 92. ABK Biomedical Description and Major Businesses
Table 93. ABK Biomedical Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. ABK Biomedical Product
Table 95. ABK Biomedical Recent Development
Table 96. Boston Scientific Corporation Information
Table 97. Boston Scientific Description and Major Businesses
Table 98. Boston Scientific Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Boston Scientific Product
Table 100. Boston Scientific Recent Development
Table 101. Medtronic Corporation Information
Table 102. Medtronic Description and Major Businesses
Table 103. Medtronic Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Medtronic Product
Table 105. Medtronic Recent Development
Table 106. Merit Medical Systems Corporation Information
Table 107. Merit Medical Systems Description and Major Businesses
Table 108. Merit Medical Systems Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Merit Medical Systems Product
Table 110. Merit Medical Systems Recent Development
Table 111. Surefire Medical Corporation Information
Table 112. Surefire Medical Description and Major Businesses
Table 113. Surefire Medical Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Surefire Medical Product
Table 115. Surefire Medical Recent Development
Table 116. Terumo Corporation Information
Table 117. Terumo Description and Major Businesses
Table 118. Terumo Drug Eluting Beads Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Terumo Product
Table 120. Terumo Recent Development
Table 121. Global Drug Eluting Beads Sales Forecast by Regions (2021-2026) (K MT)
Table 122. Global Drug Eluting Beads Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Drug Eluting Beads Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Drug Eluting Beads Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Drug Eluting Beads Sales Forecast by Country (2021-2026) (K MT)
Table 126. North America: Drug Eluting Beads Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Drug Eluting Beads Sales Forecast by Country (2021-2026) (K MT)
Table 128. Europe: Drug Eluting Beads Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Drug Eluting Beads Sales Forecast by Region (2021-2026) (K MT)
Table 130. Asia Pacific: Drug Eluting Beads Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Drug Eluting Beads Sales Forecast by Country (2021-2026) (K MT)
Table 132. Latin America: Drug Eluting Beads Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Drug Eluting Beads Sales Forecast by Country (2021-2026) (K MT)
Table 134. Middle East and Africa: Drug Eluting Beads Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Drug Eluting Beads Players
Table 139. Drug Eluting Beads Customers List
Table 140. Drug Eluting Beads Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Beads Product Picture
Figure 2. Global Drug Eluting Beads Sales Market Share by Type in 2020 & 2026
Figure 3. Oncozene Beads Product Picture
Figure 4. Quadra Sphere Product Picture
Figure 5. LC Beads Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Eluting Beads Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Specialized Clinics
Figure 10. Research Centers
Figure 11. Ambulatory Surgical Centers
Figure 12. Drug Eluting Beads Report Years Considered
Figure 13. Global Drug Eluting Beads Market Size 2015-2026 (US$ Million)
Figure 14. Global Drug Eluting Beads Sales 2015-2026 (K MT)
Figure 15. Global Drug Eluting Beads Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Drug Eluting Beads Sales Market Share by Region (2015-2020)
Figure 17. Global Drug Eluting Beads Sales Market Share by Region in 2019
Figure 18. Global Drug Eluting Beads Revenue Market Share by Region (2015-2020)
Figure 19. Global Drug Eluting Beads Revenue Market Share by Region in 2019
Figure 20. Global Drug Eluting Beads Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Drug Eluting Beads Revenue in 2019
Figure 22. Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Drug Eluting Beads Sales Market Share by Type (2015-2020)
Figure 24. Global Drug Eluting Beads Sales Market Share by Type in 2019
Figure 25. Global Drug Eluting Beads Revenue Market Share by Type (2015-2020)
Figure 26. Global Drug Eluting Beads Revenue Market Share by Type in 2019
Figure 27. Global Drug Eluting Beads Market Share by Price Range (2015-2020)
Figure 28. Global Drug Eluting Beads Sales Market Share by Application (2015-2020)
Figure 29. Global Drug Eluting Beads Sales Market Share by Application in 2019
Figure 30. Global Drug Eluting Beads Revenue Market Share by Application (2015-2020)
Figure 31. Global Drug Eluting Beads Revenue Market Share by Application in 2019
Figure 32. North America Drug Eluting Beads Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Drug Eluting Beads Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Drug Eluting Beads Sales Market Share by Country in 2019
Figure 35. North America Drug Eluting Beads Revenue Market Share by Country in 2019
Figure 36. U.S. Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Drug Eluting Beads Market Share by Type in 2019
Figure 41. North America Drug Eluting Beads Market Share by Application in 2019
Figure 42. Europe Drug Eluting Beads Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Drug Eluting Beads Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Drug Eluting Beads Sales Market Share by Country in 2019
Figure 45. Europe Drug Eluting Beads Revenue Market Share by Country in 2019
Figure 46. Germany Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Drug Eluting Beads Market Share by Type in 2019
Figure 57. Europe Drug Eluting Beads Market Share by Application in 2019
Figure 58. Asia Pacific Drug Eluting Beads Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Drug Eluting Beads Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Drug Eluting Beads Sales Market Share by Region in 2019
Figure 61. Asia Pacific Drug Eluting Beads Revenue Market Share by Region in 2019
Figure 62. China Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Drug Eluting Beads Market Share by Type in 2019
Figure 85. Asia Pacific Drug Eluting Beads Market Share by Application in 2019
Figure 86. Latin America Drug Eluting Beads Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Drug Eluting Beads Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Drug Eluting Beads Sales Market Share by Country in 2019
Figure 89. Latin America Drug Eluting Beads Revenue Market Share by Country in 2019
Figure 90. Mexico Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Drug Eluting Beads Market Share by Type in 2019
Figure 97. Latin America Drug Eluting Beads Market Share by Application in 2019
Figure 98. Middle East and Africa Drug Eluting Beads Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Drug Eluting Beads Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Drug Eluting Beads Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Drug Eluting Beads Revenue Market Share by Country in 2019
Figure 102. Turkey Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Drug Eluting Beads Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Drug Eluting Beads Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Drug Eluting Beads Market Share by Type in 2019
Figure 109. Middle East and Africa Drug Eluting Beads Market Share by Application in 2019
Figure 110. North America Drug Eluting Beads Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Drug Eluting Beads Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Drug Eluting Beads Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Drug Eluting Beads Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Drug Eluting Beads Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Drug Eluting Beads Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Drug Eluting Beads Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Drug Eluting Beads Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Drug Eluting Beads Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Drug Eluting Beads Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed